Quintiles dishes on vaccine R&D; Novo nears IT spinoff;

> Quintiles ($Q) testified before Congress about the long, expensive process of vaccine development and suggested potential policy pathways that accelerate R&D. News

> Novo Nordisk ($NVO) is gearing up to spin out its pharma IT business, NNIT, in the coming week, launching an independent contractor that will seek to do business with its parent company's rivals. Story